Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis

Chen, Sheng-YinSheng-YinChenChen, Jui-YiJui-YiChenHuang, Wei-ChiehWei-ChiehHuangPuar, Troy Hai KiatTroy Hai KiatPuarChin Kek, PengPengChin KekSHIH-CHIEH CHUEHYEN-HUNG LINVIN-CENT WUStudy Group, TaipaiTaipaiStudy Group2022-12-292022-12-292022-12-0108044643https://scholars.lib.ntu.edu.tw/handle/123456789/626795In patients with primary aldosteronism (PA), long-term cardiovascular and mortality outcomes after adrenalectomy vs mineralocorticoid receptor antagonist (MRA) have not been compared yet. We aim to compare the clinical outcomes of these patients after treatment.en[SDGs]SDG3Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysisjournal article10.1530/EJE-22-0375363154662-s2.0-85142403209